Potentiation of the glutamatergic synaptic input to rat locus coeruleus neurons by P2X7 receptors

Purinergic Signalling

Volumn 6, Issue 3, 2010, Pages 349-359

  Khakpay, Roghayeh ^a   Polster, Daniel ^a   Köles, Laszlo ^a,b   Skorinkin, Andrey ^c   Szabo, Bela ^d   Wirkner, Kerstin ^a   Illes, Peter ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c KAZAN FEDERAL UNIVERSITY   (Russian Federation)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Adenosine 5 triphosphate; Locus coeruleus; Miniature excitatory postsynaptic currents; P2X7 receptors; Presynaptic modulation; Spontaneous excitatory postsynaptic currents

Indexed keywords

EID: 77957323601     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-010-9198-3     Document Type: Article

References (53)

1. Stamford JA (1995) Descending control of pain. Br J Anaesth 75: 217-227.
2. van Bockstaele EJ, Aston-Jones G (1995) Integration in the ventral medulla and coordination of sympathetic, pain and arousal functions. Clin Exp Hypertens 17: 153-165.
3. Harms L, Finta EP, Tschöpl M, Illes P (1992) Depolarization of rat locus coeruleus neurons by adenosine 5′-triphosphate. Neuroscience 48: 941-952.
4. Shen KZ, North RA (1993) Excitation of rat locus coeruleus neurons by adenosine 5′-triphosphate: ionic mechanism and receptor characterization. J Neurosci 13: 894-899.
5. Aghajanian GK, Wang YY (1987) Common alpha 2- and opiate effector mechanisms in the locus coeruleus: intracellular studies in brain slices. Neuropharmacology 26: 793-799.
6. Cherubini E, North RA, Williams JT (1988) Synaptic potentials in rat locus coeruleus neurones. J Physiol 406: 431-442.
7. Williams JT, Bobker DH, Harris GC (1991) Synaptic potentials in locus coeruleus neurons in brain slices. Prog Brain Res 88: 167-172.
8. Egan TM, Henderson G, North RA, Williams JT (1983) Noradrenaline-mediated synaptic inhibition in rat locus coeruleus neurones. J Physiol 345: 477-488.
9. Nieber K, Poelchen W, Illes P (1997) Role of ATP in fast excitatory synaptic potentials in locus coeruleus neurones of the rat. Br J Pharmacol 122: 423-430.
10. Poelchen W, Sieler D, Wirkner K, Illes P (2001) Co-transmitter function of ATP in central catecholaminergic neurons of the rat. Neuroscience 102: 593-602.
11. Virginio C, MacKenzie A, Rassendren FA, North RA, Surprenant A (1999) Pore dilation of neuronal P2X receptor channels. Nat Neurosci 2: 315-321.
12. Sperlágh B, Vizi ES, Wirkner K, Illes P (2006) P2X7 receptors in the nervous system. Prog Neurobiol 78: 327-346.
13. 7 receptor function and immunoreactivity in neurons. Trends Neurosci 29: 257-262.
14. 7 and the inflammasome. Trends Pharmacol Sci 28: 465-472.
15. 7 in pain and inflammation. Purinergic Signal 3: 163-169.
16. Minke B, Cook B (2002) TRP channel proteins and signal transduction. Physiol Rev 82: 429-472.
17. 2 adrenoceptor- and P2 purinoceptor-functions in rat locus coeruleus neurons. Naunyn Schmiedebergs Arch Pharmacol 357: 186-189.
18. Barry PH (1994) JPCalc, a software package for calculating liquid junction potential corrections in patch-clamp, intracellular, epithelial and bilayer measurements and for correcting junction potential measurements. J Neurosci Methods 51: 107-116.
19. Khakh BS, Burnstock G, Kennedy C, King BF, North RA, Séguéla P, Voigt M, Humphrey PP (2001) International Union of Pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev 53: 107-118.
20. Jarvis MF, Khakh BS (2009) ATP-gated P2X cation-channels. Neuropharmacology 56: 208-215.
21. Marinelli S, Vaughan CW, Christie MJ, Connor M (2002) Capsaicin activation of glutamatergic synaptic transmission in the rat locus coeruleus in vitro. J Physiol 543: 531-540.
22. Nakatsuka T, Gu JG (2001) ATP P2X receptor-mediated enhancement of glutamate release and evoked EPSCs in dorsal horn neurons of the rat spinal cord. J Neurosci 21: 6522-6531.
23. Chen M, Gu JG (2005) A P2X receptor-mediated nociceptive afferent pathway to lamina I of the spinal cord. Mol Pain 1: 1-13.
24. Chizh BA, Illes P (2001) P2X receptors and nociception. Pharmacol Rev 53: 553-568.
25. Khakh BS, Henderson G (1998) ATP receptor-mediated enhancement of fast excitatory neurotransmitter release in the brain. Mol Pharmacol 54: 372-378.
26. 2+ entry through presynaptic P2X receptors elicits postsynaptic firing in the brainstem autonomic network. J Neurosci 24: 3125-3135.
27. Watano T, Calvert JA, Vial C, Forsythe ID, Evans RJ (2004) P2X receptor subtype-specific modulation of excitatory and inhibitory synaptic inputs in the rat brainstem. J Physiol 558: 745-757.
28. Hugel S, Schlichter R (2000) Presynaptic P2X receptors facilitate inhibitory GABAergic transmission between cultured rat spinal cord dorsal horn neurons. J Neurosci 20: 2121-2130.
29. Rhee JS, Wang ZM, Nabekura J, Inoue K, Akaike N (2000) ATP facilitates spontaneous glycinergic IPSC frequency at dissociated rat dorsal horn interneuron synapses. J Physiol 524: 471-483.
30. Jameson HS, Pinol RA, Mendelowitz D (2008) Purinergic P2X receptors facilitate inhibitory GABAergic and glycinergic neurotransmission to cardiac vagal neurons in the nucleus ambiguus. Brain Res 1224: 53-62.
31. Wirkner K, Köfalvi A, Fischer W, Günther A, Franke H, Gröger-Arndt H, Nörenberg W, Madarász E, Vizi ES, Schneider D, Sperlágh B, Illes P (2005) Supersensitivity of P2X receptors in cerebrocortical cell cultures after in vitro ischemia. J Neurochem 95: 1421-1437.
32. von Kügelgen I (2006) Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacol Ther 110: 415-432.
33. 4 receptor channels expressed in human embryonic kidney cells. Neurosci Lett 279: 165-168.
34. Tschöpl M, Harms L, Nörenberg W, Illes P (1992) Excitatory effects of adenosine 5′-triphosphate on rat locus coeruleus neurones. Eur J Pharmacol 213: 71-77.
35. Fröhlich R, Boehm S, Illes P (1996) Pharmacological characterization of P2 purinoceptor types in rat locus coeruleus neurons. Eur J Pharmacol 315: 255-261.
36. Fields RD, Burnstock G (2006) Purinergic signalling in neuron-glia interactions. Nat Rev Neurosci 7: 423-436.
37. Burnstock G (2006) Historical review: ATP as a neurotransmitter. Trends Pharmacol Sci 27: 166-176.
38. Illes P, Ribeiro AJ (2004) Molecular physiology of P2 receptors in the central nervous system. Eur J Pharmacol 483: 5-17.
39. 7 receptor-mediated release of excitatory amino acids from astrocytes. J Neurosci 23: 1320-1328.
40. 2+ signaling. J Neurosci 26: 1378-1385.
41. Abbracchio MP, Ceruti S (2006) Roles of P2 receptors in glial cells: focus on astrocytes. Purinergic Signal 2: 595-604.
42. 13 purinergic receptors mediate intracellular calcium responses to BzATP in rat cerebellar astrocytes. J Neurochem 110: 879-889.
43. Fellin T, Pozzan T, Carmignoto G (2006) Purinergic receptors mediate two distinct glutamate release pathways in hippocampal astrocytes. J Biol Chem 281: 4274-4284.
44. 5 subunits form the functional P2X receptor in mouse cortical astrocytes. J Neurosci 28: 5473-5480.
45. Surprenant A, North RA (2009) Signaling at purinergic P2X receptors. Annu Rev Physiol 71: 333-359.
46. 7 receptors in mouse parotid acinar and duct cells. J Biol Chem 278: 47554-47561.
47. 7 receptors control 2-arachidonoylglycerol production by microglial cells. Proc Natl Acad Sci USA 101: 3214-3219.
48. 7 receptor: a key player in IL-1 processing and release. J Immunol 176: 3877-3883.
49. 7 receptors is dependent on inflammasome activation and correlated with exosome release in murine macrophages. J Immunol 179: 1913-1925.
50. Clarke DD (1991) Fluoroacetate and fluorocitrate: mechanism of action. Neurochem Res 16: 1055-1058.
51. Huck S, Grass F, Hörtnagl H (1984) The glutamate analogue alpha-aminoadipic acid is taken up by astrocytes before exerting its gliotoxic effect in vitro. J Neurosci 4: 2650-2657.
52. Deleuze C, Duvoid A, Hussy N (1998) Properties and glial origin of osmotic-dependent release of taurine from the rat supraoptic nucleus. J Physiol 507: 463-471.
53. McBean GJ (1994) Inhibition of the glutamate transporter and glial enzymes in rat striatum by the gliotoxin, α-aminoadipate. Br J Pharmacol 113: 536-540.